2-(1,1-dimethylethyl)-2-hexanamine | 99868-56-1

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-(1,1-dimethylethyl)-2-hexanamine
• 英文别名: (+/-)-3-Amino-2,2,3-trimethyl-heptan；1-tert-butyl-1-methyl-pentylamine；2,2,3-Trimethylheptan-3-amine
• CAS: 99868-56-1
• 化学式: C₁₀H₂₃N
• 分子量: 157.299
• InChiKey: RNBQPJIOZCICNJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  聚合甲醛 、 2-(1,1-dimethylethyl)-2-hexanamine 在 甲酸 作用下， 生成 (+/-)-3-Dimethylamino-2,2,3-trimethyl-heptan
  参考文献：
  名称：

  Substituierte t-Hexylamine als neuer Typ hypotensiv wirksamer Verbindungen

  摘要：

  DOI：

  10.1007/bf02158110
• 作为产物：
  描述：

  频哪酮 在 盐酸 作用下， 生成 2-(1,1-dimethylethyl)-2-hexanamine
  参考文献：
  名称：

  Vejdelek,Z.J. et al., Collection of Czechoslovak Chemical Communications, 1970, vol. 35, p. 2814 - 2830

  摘要：

  DOI：

文献信息

• Immunomodulators
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US10450347B2

  公开（公告）日：2019-10-22

  The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.

  本公开提供了新型大环肽，它们能抑制 PD-1/PD-L1 和 PD-L1/CD80 蛋白/蛋白相互作用，因此可用于改善各种疾病，包括癌症和传染性疾病。
• Tertiary carbinamines by addition of organocerium reagents to nitriles and ketimines
  作者：Engelbert Ciganek

  DOI：10.1021/jo00042a037

  日期：1992.7

  Organocerium reagents, prepared by reaction of aromatic and primary and secondary alkyllithium reagents with anhydrous cerium chloride, add to nitriles twice to give tertiary carbinamines in often excellent yields. Addition of n-BuCeCl2 to acetophenone is about 4 times faster than addition to benzonitrile. Only 1,2-diaddition is observed in the reaction of MeCeCl2 with cinnamonitrile. The species formed in the double addition of organocerium reagents to nitriles are sufficiently basic to generate a benzyne intermediate by abstraction of an aromatic proton and nucleophilic enough to undergo an intramolecular Chichibabin reaction. Reaction of N-unsubstituted ketimines or their lithium salts with organocerium reagents permits the synthesis of tertiary carbinamines with three different groups on the tertiary carbon center.
• IMMUNOMODULATORS
  申请人：BRISTOL-MYERS SQUIBB COMPANY

  公开号：US20170283462A1

  公开（公告）日：2017-10-05

  The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.